ONESOURCE — Onesource Specialty Pharma Cashflow Statement
0.000.00%
- IN₹210.32bn
- IN₹224.16bn
- IN₹14.22bn
Annual cashflow statement for Onesource Specialty Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -4,156 | -3,657 | -671 | -920 |
| Depreciation | ||||
| Non-Cash Items | 1,061 | 1,672 | 1,522 | 1,067 |
| Discontinued Operations | ||||
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 326 | -41.3 | -4,269 | -2,853 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -1,628 | -1,072 | -678 | 85.2 |
| Capital Expenditures | -440 | -638 | -1,281 | -5,691 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -238 | 5,743 | -729 | 741 |
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Change in Net Intangibles | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -678 | 5,105 | -2,011 | -4,950 |
| Financing Cash Flow Items | -1,053 | -1,033 | -1,565 | -1,191 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1,183 | -3,905 | 4,120 | 3,594 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -1,123 | 128 | 1,431 | -1,270 |